Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keae148DOI Listing

Publication Analysis

Top Keywords

comment achieving
4
achieving inactive
4
inactive disease
4
disease enthesitis-related
4
enthesitis-related arthritis
4
arthritis secukinumab
4
secukinumab tnf-inhibitor
4
tnf-inhibitor failure
4
comment
1
inactive
1

Similar Publications

This paper intends to solve the limitations of the existing methods to deal with the comments of tourist attractions. With the technical support of Artificial Intelligence (AI), an online comment method of tourist attractions based on text mining model and attention mechanism is proposed. In the process of text mining, the attention mechanism is used to calculate the contribution of each topic to text representation on the topic layer of Latent Dirichlet Allocation (LDA).

View Article and Find Full Text PDF

Background: Activity-based therapy (ABT) has shown promise as a viable therapeutic intervention to promote neurorecovery in people with spinal cord injury/disease (SCI/D). Tools that track the details of ABT sessions may facilitate the collection of data needed to inform best practice guidelines for ABT.

Objective: The purpose of this study was to evaluate the content validity of a prototype ABT tracking tool.

View Article and Find Full Text PDF

Introduction: Chile has achieved developed nation status and boasts a life expectancy of 81 + years; however, the healthcare and research systems are unprepared for the social and economic burden of cancer. One decade ago, the authors put forward a comprehensive analysis of cancer infrastructure, together with a series of suggestions on research orientated political policy.

Objectives: Provide an update and comment on policy, infrastructure, gender equality, stakeholder participation and new challenges in national oncology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!